Literature DB >> 8906805

Lack of IL-12 signaling in human allergen-specific Th2 cells.

C M Hilkens1, G Messer, K Tesselaar, A G van Rietschoten, M L Kapsenberg, E A Wierenga.   

Abstract

IL-12 is a powerful skewer of CD4+ T cell responses toward the Th1 phenotype by inducing IFN-gamma production in naive Th cells. In the present study we addressed the question of whether IL-12 can reverse established Th2 responses into Th1/Th0 responses by inducing IFN-gamma production in memory Th2 cells. To this aim, allergen-specific CD4+ T cell clones (TCC) were generated from the peripheral blood of three atopic patients, and their cytokine profiles were analyzed. The majority of these TCC exhibited a strongly polarized Th2 cytokine profile, and the production of IFN-gamma could not be induced by exogenous IL-12. Only those TCC with low IFN-gamma levels in the absence of IL-12 responded to IL-12 by additional enhancement of IFN-gamma production. The IL-12 nonresponsiveness of the Th2 clones was further evident by the total lack of IL-12-induced phosphorylation of STAT4 (signal transducer and activator of transcription-4), a transcription factor that is typically involved in IL-12 signaling. Consequently, IL-12 also failed to induce the DNA-binding activity of STAT4-containing complexes in the nuclei of these Th2 clones. All TCC expressed equal levels of the low-affinity IL-12R beta1 subunit. Our results indicate that human allergen-specific Th cells with strongly polarized Th2 cytokine profiles do not respond to IL-12 and, therefore, cannot be induced to produce IFN-gamma. The apparent high frequency of IL-12-nonresponsive Th cells within the allergen-specific populations in atopic patients predicts a limited skewing potential of IL-12 in the case of established Th2 responses, but only affecting newly recruited naive Th cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8906805

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  Host resistance against Candida alibcans infection in mice with adjuvant induced arthritis.

Authors:  Martin Yordanov; Anna Deleva; Nina Ivanovska
Journal:  Mycopathologia       Date:  2002       Impact factor: 2.574

2.  Limited impact of multiple 5' single-nucleotide polymorphisms on the transcriptional control of the human beta 2-adrenoceptor gene.

Authors:  Robert Westland; Anneke van Veen; Henk M Jansen; Rene E Jonkers; Eddy A Wierenga
Journal:  Immunogenetics       Date:  2004-11-17       Impact factor: 2.846

3.  mRNA expression and RNA editing (2451 C-to-U) of IL-12 receptor beta2 in adult atopic patients.

Authors:  Eun Jin Kim; Won Mok Lee; Jung Sook Ha; Nam Hee Ryoo; Dong Suk Jeon; Jae Ryong Kim
Journal:  J Korean Med Sci       Date:  2006-12       Impact factor: 2.153

Review 4.  Immunological mechanisms in specific immunotherapy.

Authors:  Carsten B Schmidt-Weber; Kurt Blaser
Journal:  Springer Semin Immunopathol       Date:  2003-10-24

Review 5.  Regulation of T helper cell subsets by cyclooxygenases and their metabolites.

Authors:  Hong Li; Matthew L Edin; Artiom Gruzdev; Jennifer Cheng; J Alyce Bradbury; Joan P Graves; Laura M DeGraff; Darryl C Zeldin
Journal:  Prostaglandins Other Lipid Mediat       Date:  2012-11-28       Impact factor: 3.072

6.  Residual type 1 immunity in patients genetically deficient for interleukin 12 receptor beta1 (IL-12Rbeta1): evidence for an IL-12Rbeta1-independent pathway of IL-12 responsiveness in human T cells.

Authors:  C E Verhagen; H H Smits; F A Verreck; E A Wierenga; M Kurimoto; D A Lammas; D S Kumararatne; O Sanal; F P Kroon; F Sinigaglia; T H Ottenhoff
Journal:  J Exp Med       Date:  2000-08-21       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.